Combination p53 activation and BCL-xL/BCL-2 inhibition as a therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia
Article in Leukemia (April 2024)
The most recent citing publications are shown below. View all 76 publications that cite this research output on Dimensions.
Article in Leukemia (April 2024)
Article in Journal of Experimental & Clinical Cancer Research (March 2024)
Article in Epigenetics & Chromatin (March 2024)